Recruiting
Phase 3
Psychosis Associated With Alzheimer's Disease Karuna Therapeutics, Inc., a Bristol Myers Squibb company · started 2023-08-28
Ilford · Swinton · London · Aberdeen · Chertsey
NCT06126224 on ClinicalTrials.gov ↗
Active
Phase 3
Primary Prevention of Atherosclerotic Cardiovascular Disease Novartis Pharmaceuticals · started 2023-03-09
Luton · High Wycombe · Peterborough · Connor Downs · Fowey
NCT05739383 on ClinicalTrials.gov ↗
Active
Phase 3
Follicular Lymphoma, Marginal Zone Lymphoma Incyte Corporation · started 2021-04-15
Birmingham · Bristol · Leicester · London · Manchester
NCT04680052 on ClinicalTrials.gov ↗
Recruiting
Phase 1
Ovarian Cancer, Squamous Non-Small Cell Lung Cancer (NSCLC), Synovial Sarcomas, Head and Neck Cancer Zelluna Immunotherapy AS · started 2026-05-11
NCT07613723 on ClinicalTrials.gov ↗
Recruiting
Phase 1
Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer Pfizer · started 2025-08-20
NCT07090499 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE ADARx Pharmaceuticals, Inc. · started 2026-04-02
Cambridge · Cardiff · London · Southampton
NCT07428499 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Diabetes Mellitus, Type 1 Eli Lilly and Company · started 2026-01-12
Birmingham · Cambridge · Cardiff · Glasgow · London
NCT07222137 on ClinicalTrials.gov ↗
Recruiting
Phase 3
CACNA1A, Spinocerebellar Ataxia Type 6, Episodic Ataxia Type 2, Familial Hemiplegic Migraine-1 IntraBio Inc · started 2026-08-17
NCT07221292 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Cardiovascular Disease and Lipoprotein(a) Novartis Pharmaceuticals · started 2026-05-11
Dorchester · London · Preston · Harrow · Rochdale
NCT07517263 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Diabetes Mellitus, Type 1 Eli Lilly and Company · started 2026-02-05
Aberdeen · Birmingham · Bristol · Cambridge · Cardiff
NCT07222332 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Systemic Lupus Erythematosus UCB Biopharma SRL · started 2024-11-21
Bath · Belfast · Leeds · London · Newcastle upon Tyne
NCT06617325 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Non-small Cell Lung Cancer (NSCLC) AstraZeneca · started 2025-10-31
Huddersfield · London · Maidstone · Norwich · Stoke-on-Trent
NCT07291037 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD) Eli Lilly and Company · started 2025-09-02
Belfast · Birmingham · Blackpool · Bodelwyddan · Bradford-on-Avon
NCT07157774 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Small-cell Lung Cancer Zai Lab (Shanghai) Co., Ltd. · started 2025-11-30
Cambridge · London · Chelsea · Sutton · Stoke-on-Trent
NCT07218146 on ClinicalTrials.gov ↗
Active
Phase 2/Phase 3
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus Biogen · started 2022-09-13
London · Manchester · Birmingham · Leeds
NCT05531565 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma Pfizer · started 2025-09-29
NCT07144280 on ClinicalTrials.gov ↗
Active
Phase 3
Generalized Anxiety Disorder Definium Therapeutics US, Inc. · started 2025-01-29
Glasgow · Gosforth · London · Manchester · Sheffield
NCT06809595 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Neovascular Age-related Macular Degeneration AbbVie · started 2025-11-05
Gloucester · London · Liverpool · Bristol · Sunderland
NCT07007065 on ClinicalTrials.gov ↗
Recruiting
Phase 1/Phase 2
Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors Turning Point Therapeutics, Inc. · started 2020-03-12
Liverpool · Birmingham · Cardiff · Glasgow · London
NCT04094610 on ClinicalTrials.gov ↗
Recruiting
Phase 1
Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm Eli Lilly and Company · started 2024-07-01
NCT06465069 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Idiopathic Pulmonary Fibrosis (IPF) Rein Therapeutics · started 2026-02-02
Birmingham · Edgbaston · Trumpington · Exeter · Oxford
NCT06968845 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Merck Sharp & Dohme LLC · started 2025-04-09
Cambridge · Edinburgh · Preston · London · Sutton
NCT06824467 on ClinicalTrials.gov ↗
Recruiting
Phase 2
IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN) ADARx Pharmaceuticals, Inc. · started 2025-08-28
Leicester · Newcastle upon Tyne
NCT06989359 on ClinicalTrials.gov ↗
Recruiting
Phase 1/Phase 2
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma Merck Sharp & Dohme LLC · started 2024-08-16
Birmingham · Newcastle upon Tyne · London · Sutton · Cardiff
NCT06395103 on ClinicalTrials.gov ↗
Recruiting
Phase 1/Phase 2
Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer Merck Sharp & Dohme LLC · started 2024-06-20
NCT06428409 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Geographic Atrophy Secondary to Age-related Macular Degeneration ADARx Pharmaceuticals, Inc. · started 2025-11-10
Liverpool · Dorchester · Wolverhampton · London · Sunderland
NCT06990269 on ClinicalTrials.gov ↗
Recruiting
Phase 3
PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer Relay Therapeutics, Inc. · started 2025-08-26
Bath · Cardiff · London · Manchester · Swindon
NCT06982521 on ClinicalTrials.gov ↗
Active
Heart Failure Foundry Innovation & Research 1, Limited (FIRE1) · started 2019-11-22
Bournemouth · Glasgow · Leicester · London · Portsmouth
NCT04203576 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases Boehringer Ingelheim · started 2025-07-22
Birmingham · Blackburn · Bournemouth · Bradford · Bristol
NCT07064473 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Prostate Cancer Metastatic Merck Sharp & Dohme LLC · started 2023-12-31
Cambridge · Truro · Glasgow · London · Manchester
NCT06136624 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer Astellas Pharma Global Development, Inc. · started 2025-08-19
NCT07005154 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis 89bio, Inc. · started 2024-05-24
Aberdeen · Bristol · Leeds · London · Oxford
NCT06419374 on ClinicalTrials.gov ↗
Starting soon
Phase 3
Interstitial Lung Diseases Boehringer Ingelheim · started 2026-09-14
Birmingham · Exeter · Leeds · Leicester · London
NCT07540988 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Chronic Obstructive Pulmonary Disease (COPD) AstraZeneca · started 2025-03-18
Bradford · Brighton · Cottingham · Glasgow · Halifax
NCT06883305 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Non-small Cell Lung Cancer, NSCLC Merck Sharp & Dohme LLC · started 2024-06-10
Londonderry · Torquay · London · Nottingham
NCT06422143 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Ovarian Neoplasms, Ovarian Cancer Merck Sharp & Dohme LLC · started 2026-02-16
Cambridge · Leicester · London · Manchester
NCT07318558 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Atherosclerotic Cardiovascular Disease, Overweight, Obesity Amgen · started 2025-07-25
Birmingham · Blackpool · Bristol · Cambridge · Chester
NCT07037433 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Solid Tumors, Hematologic Malignancies Merck Sharp & Dohme LLC · started 2018-08-21
Aberdeen · Cambridge · Edinburgh · Manchester · Sheffield
NCT03486873 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Lymphoma, Large B-Cell, Diffuse Merck Sharp & Dohme LLC · started 2025-04-11
Bristol · Aylesbury · Exeter · Plymouth · Middlesbrough
NCT06890884 on ClinicalTrials.gov ↗
Starting soon
Phenylketonuria (PKU) and Hyperphenylalaninemia, Brain Diseases, Metabolic, Inborn, Brain Disorder, Metabolic, Brain Diseases metaX Institut fuer Diatetik GmbH · started 2026-10-01
NCT07802366 on ClinicalTrials.gov ↗
Recruiting
Phase 1/Phase 2
Prostatic Neoplasms, Castration-Resistant Merck Sharp & Dohme LLC · started 2024-05-20
Cambridge · Glasgow · Preston · London · Birmingham
NCT06353386 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease, Advanced Gastrointestinal Stromal Tumor Merck Sharp & Dohme LLC · started 2021-08-12
Cambridge · London · Glasgow
NCT04924075 on ClinicalTrials.gov ↗
Recruiting
Phase 2
Obesity, Overweight Boehringer Ingelheim · started 2026-06-30
Blackpool · Guisborough · High Wycombe · Leicester · Middlesbrough
NCT07662122 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Metabolic Dysfunction Associated Steatohepatitis Boehringer Ingelheim · started 2024-11-12
Aberdeen · Bristol · Camberley · Derby · Edgbaston, Birmingham
NCT06632457 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Prostate Cancer, Prostatic Neoplasms Merck Sharp & Dohme LLC · started 2025-05-13
Cambridge · London · Exeter · Birmingham · Northwood
NCT06925737 on ClinicalTrials.gov ↗
Recruiting
Phase 2/Phase 3
DLBCL, Diffuse Large B-Cell Lymphoma Merck Sharp & Dohme LLC · started 2022-01-14
Aberdeen · Truro · London-Camden
NCT05139017 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Non-small Cell Lung Cancer (NSCLC) Merck Sharp & Dohme LLC · started 2023-12-15
London · Portsmouth · Canterbury · Central Middlesbrough
NCT06170788 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Locally Advanced Head and Neck Squamous Cell Carcinoma AstraZeneca · started 2023-12-14
Aberdeen · Cambridge · Hampshire · Leeds · London
NCT06129864 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis 89bio, Inc. · started 2024-03-13
High Wycombe · Bristol · Glasgow · Hull · London
NCT06318169 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Triple Negative Breast Neoplasms Merck Sharp & Dohme LLC · started 2025-03-16
Truro · London · Nottingham · Taunton · Birmingham
NCT06841354 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Von Hippel-Lindau Disease, Malignant Neoplasms Merck Sharp & Dohme LLC · started 2026-03-23
Glasgow · London · Manchester
NCT07405164 on ClinicalTrials.gov ↗
Recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration Complement Therapeutics · started 2025-07-30
Gloucester · London · Southampton · Sunderland · Belfast
NCT07144137 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms Merck Sharp & Dohme LLC · started 2025-06-30
London · Dundee · Huddersfield · Colchester · Orpington
NCT06966700 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Obesity With Diabetes, Overweight With Diabetes Kailera · started 2026-01-12
Truro · Plymouth · Bournemouth · Hull · Glasgow
NCT07284901 on ClinicalTrials.gov ↗
Recruiting
Phase 1/Phase 2
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Merck Sharp & Dohme LLC · started 2026-05-03
NCT07519772 on ClinicalTrials.gov ↗
Active
Phase 3
Metastatic Pancreatic Ductal Adenocarcinoma Arcus Biosciences, Inc. · started 2024-12-13
Birmingham · Cottingham · London · Manchester
NCT06608927 on ClinicalTrials.gov ↗
Recruiting
Phase 1/Phase 2
Renal Cell Carcinoma Merck Sharp & Dohme LLC · started 2025-07-20
Edinburgh · Glasgow · London · Cardiff · Manchester
NCT07049926 on ClinicalTrials.gov ↗
Recruiting
Phase 3
Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia Crinetics Pharmaceuticals Inc. · started 2025-12-11
Cardiff · London · Manchester · Sheffield
NCT07144163 on ClinicalTrials.gov ↗
No trials match your search.